Related Experiment Video

Updated: Sep 26, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Uremia-related metabolic cardiac risk factors in chronic kidney disease

François Madore1

  • 1Renal Division, Department of Medicine, Hôpital du Sacré-Coeur, University of Montreal, Quebec, Canada. f-madore@crhsc.umontreal.ca

Seminars in Dialysis
|March 19, 2003
PubMed

Insights

Uremia-related factors like dyslipidemia and inflammation contribute to atherosclerosis in chronic kidney disease (CKD) patients. This review examines their cardiac risk and management, offering treatment recommendations for these cardiovascular disease risks.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Atherosclerosis Research

Background:

  • Nontraditional risk factors are increasingly implicated in atherosclerosis pathogenesis in renal failure.
  • Dyslipidemia, inflammation, hyperhomocysteinemia, and oxidant stress are key studied uremia-related factors.
  • The clinical significance of these factors in chronic kidney disease (CKD) remains debated.

Purpose of the Study:

  • To review existing evidence on uremia-related risk factors in atherosclerosis.
  • To emphasize prevalence, cardiac risk, and management strategies in CKD patients.
  • To provide consensus treatment recommendations for actionable risk factors.

Main Methods:

  • Comprehensive literature review of studies over the last 15 years.
  • Analysis of evidence concerning atherosclerosis pathogenesis in renal failure.
  • Focus on dyslipidemia, inflammation, hyperhomocysteinemia, and oxidant stress.
  • Evaluation of clinical significance and cardiac risk.

Main Results:

  • Growing evidence links uremia-related factors to atherosclerosis in CKD.
  • Clinical significance of factors like dyslipidemia and inflammation is still under investigation.
  • Prevalence and cardiac risk associated with these factors in CKD patients are highlighted.

Conclusions:

  • Uremia-related factors play a significant role in atherosclerosis development in CKD.
  • Further research is needed to clarify the clinical impact of certain factors.
  • Evidence-based treatment recommendations are crucial for managing cardiovascular risk in CKD.

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...